Luis RodrÃguez-Borlado
Coretherapix SLU, Spain
Biography
Luis RodrÃguez-Borlado has a PhD in Biochemistry and Molecular Biology from the University Autónoma of Madrid with the study of molecular bases of immune system development. After developing a scientific career in academic laboratories in Spain and The Netherlands developing high-throughput screenings to identify new therapeutic cancer targets, he joined Coretherapix in 2008 (a company belonging to the Genetrix group). At Coretherapix he has been responsible for designing the cell characterization and pre-clinical studies enabling the filing of the IMPD corresponding to Coretherapix’s first cell candidate product, a task he has led in his role of Scientific Director.
Abstract
Abstract : Challenges in I+D development of an advanced medicine product